BBlogFlow

New UK CMO activity guidelines show every movement counts - GOV.UK

·Jul 10, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. GOV.UK

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

KukiMAT: Ready to respond when every minute counts - World Health Organization (WHO)

For the Cook Islands, emergencies do not always happen close to the capital. A cyclone, disease outbreak, or emergency can affect communities in the Pa Enua (outer islands), separated by hundreds of kilometres of ocean. When that happens, having the capacity to quickly deploy trained personnel, equipment, and supplies to provide an initial clinical response is essential. That is why the Cook Islands Medical Assistance Team (KukiMAT), the emergency medical team arm of Te Marae Ora (TMO) – Cook Islands Ministry of Health, has been steadily building its readiness to respond. Made up of doctors, nurses, public health professionals and support personnel, the team is preparing to be able to rapidly deploy wherever help is needed, whether in Rarotonga, the Pa Enua, and one day perhaps beyond the country’s shores. In Rarotonga, we met with Dr Deacon Teapa, Medical Specialist and Director of Hospital Health Services at TMO. He explained how important it was to build the capacity of their team to be able to respond to disasters and emergencies. He acknowledged the support of the World Health Organization (WHO) and other partners including the New Zealand Medical Assistance Team (NZMAT).

World Health Organization (WHO)·

Bioengineer.org | Viral blips during HIV therapy are common and rarely signal treatment failure, Swedish study finds - European AIDS Treatment Group

Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.

European AIDS Treatment Group·

European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group

European Medical Journal news storyPeople living with HIV may experience subtle changes in heart muscle function even when conventional measures of cardiac performance remain normal, according to findings from a systematic review and meta-analysis. Researchers identified significantly impaired global longitudinal strain (GLS) among people with HIV compared with HIV-uninfected individuals, despite preserved left ventricular ejection fraction (LVEF) in both groups. The findings suggest that speckle-tracking echocardiography (STE) could provide additional information about early myocardial dysfunction in this population. Read the full news story here.

European AIDS Treatment Group·

Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Medical Xpress·